Qiagen N.V.
QGEN- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001015820
No open-market purchases or sales by Qiagen N.V. insiders were filed in the last 90 days; 337 institutions reported holding it in 13F filings for Q2 2026, worth $5.68B in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Qiagen N.V. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 337
- −4 vs. Q1 2026
- Shares held
- 146.0M
- +20.8M (+16.7%) vs. Q1 2026
- Total value
- $5.68B
- +$682.1M (+13.6%) vs. Q1 2026
- New holders
- 69
- 143 more added
- Sold out
- 73
- 89 more reduced
5 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting QGEN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 337 | $5.68B |
| Q1 2026 | 346 | $5.02B |
| Q4 2025 | 322 | $6.77B |
| Q3 2025 | 339 | $6.84B |
| Q2 2025 | 318 | $7.23B |
| Q1 2025 | 300 | $5.92B |
| Q4 2024 | 325 | $6.60B |
| Q3 2024 | 330 | $7.05B |
| Q2 2024 | 305 | $6.22B |
| Q1 2024 | 282 | $5.83B |
| Q4 2023 | 278 | $6.09B |
| Q3 2023 | 279 | $5.40B |
| Q2 2023 | 283 | $6.14B |
| Q1 2023 | 288 | $6.23B |
| Q4 2022 | 300 | $6.76B |
| Q3 2022 | 297 | $5.73B |
| Q2 2022 | 289 | $6.11B |
| Q1 2022 | 294 | $6.39B |
| Q4 2021 | 302 | $7.40B |
| Q3 2021 | 267 | $6.77B |
| Q2 2021 | 259 | $5.98B |
| Q1 2021 | 276 | $5.97B |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Qiagen N.V.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sound Income Strategies, LLC | 0 | $0 | 0.00% | −81−100.0% | Sold out |
| Root Financial Partners, LLC | 0 | $0 | 0.00% | −47−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Innovative Asset Advisors Group, LLC | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Private Wealth Management Group, LLC | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| MBM Wealth Consultants, LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Montag A & Associates Inc | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Bogart Wealth, LLC | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Central Trust Co | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Signature Equity Partners, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Janus Henderson Group PLC | – | – | – | – | Not filed |
| GM Advisory Group, Inc. | – | – | – | – | Not filed |
| CWM, LLC | – | – | – | – | Not filed |
| McIlrath & Eck, LLC | – | – | – | – | Not filed |
| Sunbelt Securities, Inc. | – | – | – | – | Not filed |